Skip to main content
. Author manuscript; available in PMC: 2016 Apr 4.
Published in final edited form as: Clin Exp Metastasis. 2015 Jun 13;32(6):555–566. doi: 10.1007/s10585-015-9727-0

Fig 7. Daily treatment of GGOHBP does not alter Rap1A prenylation in non-tumor burdened mice.

Fig 7

Western blot analysis of Rap1A in the (a) heart, (b) kidney, and (c) adrenal gland tissues of non-tumor bearing mice treated with the vehicle (mice 1 and 2), 1.25 mg/kg (mice 3 and 4) or 1.5 mg/kg (mice 5 and 6) GGOHBP daily for 31 days. The Rap1A antibody detects the unprenylated form of Rap1A as indicated by the positive control 10 μM lovastatin treatment in luciferase-expressing 22Rv1 cells